Difference between revisions of "Postmortem Chemotherapy"
Line 2: | Line 2: | ||
− | '''Patient Selection''' | + | '''Types of Postmortem Chemotherapy''' |
+ | ---- | ||
+ | The '''postmortem chemotherapy''' regimens available are varied depending on the type of metastatic cancer that killed the patient. | ||
+ | |||
+ | |||
+ | '''Patient Selection for Postmortem Chemotherapy''' | ||
---- | ---- | ||
Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> | Candidates for '''postmortem chemotherapy''' most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."<ref>[http://gomerblog.com/2016/11/hospital-morgue/ Hospital Morgue Morning Rounds Initiated After Family Insists Patient “is a Fighter”]</ref> |
Revision as of 17:22, 28 January 2017
Recently approved by the FDA, postmortem chemotherapy is a radical form of medical treatment in which "a ray of hope is offered to those who are no longer with us" by administering chemotherapy anywhere within 1 month and up to 5 years after a patient's death.[1]
Types of Postmortem Chemotherapy
The postmortem chemotherapy regimens available are varied depending on the type of metastatic cancer that killed the patient.
Patient Selection for Postmortem Chemotherapy
Candidates for postmortem chemotherapy most undergo a rigorous selection process during which they must prove their lack of functional status but are clearly still "a fighter."[2]
Does It Work?
If postmortem chemotherapy continues its current rate of success, then by the end of 2017 100% of decreased patients should remain dead.
References